Exhibit 16.1

MOORE & ASSOCIATES, CHARTERED
  ACCOUNTANTS AND ADVISORS
      PCAOB REGISTERED


August 4, 2009

U. S. Securities and Exchange Commission
450 Fifth Street NW
Washington DC  20549

Re: Enox Biopharma, Inc.

Dear Sirs:

We were previously the principal auditors for Enox Biopharma, Inc. and we
reported on the financial statements of Enox Biopharma, Inc. for the period from
inception, June 28, 2007 to June 30, 2009. We have read Enox Biopharma's
statements under Item 4 of its Form 8-K, dated August 4, 2009, and we agree with
such statements.

For the most recent fiscal period through to August 4, there have been no
disagreements between COMPANY and Moore & Associates, Chtd. on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreement, if not resolved to the satisfaction of
Moore & Associates, Chtd. would have caused it to make a reference to the
subject matter of the disagreement in connection with its reports.

Yours truly,


/s/ Moore & Associates, Chartered
- ----------------------------------------
Moore & Associates, Chartered
Las Vegas, Nevada



                 6490 West Desert Inn Road, Las Vegas, NV 89146
                        (702) 253-7499 Fax (702) 253-7501